Tonix Pharmaceuticals Holding Corp.TNXPNASDAQ

52-Week Range13-70

13.07Current 15.7769.97

Want to monitor TNXP?

Get notified when price crosses targets, volume spikes, or RSI hits oversold

Gross Margin

Operating Margin

Revenue Growth

tonix is developing innovative pharmaceutical products to address major public health challenges.

Professional, Scientific, and Technical Services

Research and Development in Biotechnology (except Nanobiotechnology)

Seth Lederman

Explore More

Filter and sort all 500 stocks

Today's biggest gainers and losers

Visual sector performance

Alerts

News

Giyani Metals advances K.Hill project in Botswana with new funding, plant data

Micron's stock is spectacularly cheap, as these numbers show

AITX's RAD Books 5 RIO 360 Units for Downtown Civic Center in Major Midwest City

Cruise Stock Flashing Can't-Miss ‘Buy The Dip' Signal

GARTNER INVESTOR ALERT: Bragar Eagel & Squire, P.C. Announces that a Class Action Lawsuit Has Been Filed Against Gartner, Inc. and Encourages Investors to Contact the Firm

Unilever in talks to sell food business to McCormick

The Dow's losing streak, fertilizer prices, Novo Nordisk's new Wegovy shot and more in Morning Squawk

Visionary Copper and Gold Mines Inc. Announces Results of Annual General Meeting

Endeavour Announces Renewal of Normal Course Issuer Bid

Ondas Reports Revised Preliminary Fourth Quarter and Full Year 2025 Financial Results and will Report Final Results on March 25, 2026 at 8:30 a.m. ET

Unusual Machines Announces Pricing of Approximately $150 Million Public Offering of Common Stock

Snail Games Leverages GDC 2026 Momentum to Drive Portfolio Growth Through Steam Spring Sale 2026 Featuring ARK: Survival Ascended, Echoes of Elysium, and Bellwright

Caris Life Sciences Announces Another Breakthrough Study for GPSai in Identifying and Correcting Misdiagnosis of Cancer Patients

Holley Performance Brands Acquires HRX, Expanding Safety & Racing Portfolio

AudioEye to Participate in 38th Annual ROTH Investor Conference

TRNR Authorizes First Stock Repurchase Program; $500,000 Program Represents 20% Of Shares Outstanding at Last Closing Price

FNB Selected as Penn State's Official Provider of Retail Banking and Financial Services

Perma-Fix Schedules Fourth Quarter and Fiscal 2025 Business Update Conference Call

West Bancorporation, Inc. to Announce Quarterly Results, Hold Conference Call

I Quit, Let Prices Fall

About